Nasdaq Welcomes NovoCure Limited to The Nasdaq Stock Market
October 02 2015 - 10:55AM
Nasdaq (Nasdaq:NDAQ) announced that trading of NovoCure Limited
(Nasdaq:NVCR) commenced on The Nasdaq Stock Market on October 2,
2015.
A photo accompanying this release is available
at http://www.globenewswire.com/NewsRoom/AttachmentNg/85f1ec95-8e1c-43e2-95e4-f690ed69b36e
NovoCure Limited is a commercial-stage oncology business
pioneering a novel therapy for solid tumors called Tumor Treating
Fields or TTFields. TTFields is a low toxicity anti-mitotic
treatment that uses low-intensity, intermediate frequency,
alternating electric fields to exert physical forces on key
molecules inside cancer cells, disrupting the basic machinery
necessary for normal cell division, leading to cancer cell death.
Headquartered in the Bailiwick of Jersey, Novocure has operations
in the United States, Switzerland, Germany, Japan and Israel and
has treated more than 1,640 patients to date with TTFields
therapy.
“Novocure’s non-invasive, wearable TTFields therapy represents a
completely new modality for treating cancer and we are excited to
welcome Novocure to our family of listed companies,” said Nelson
Griggs, Executive Vice President, Listing Services, Nasdaq. “We
look forward to supporting its success and growth in the
future.”
By listing on Nasdaq, NovoCure Limited joins many of the world’s
largest and most revolutionary companies. Nasdaq is the exchange of
choice for 78 percent of healthcare companies that have listed on
the U.S. markets year-to-date.
The information contained above is provided for informational
and educational purposes only, and nothing contained herein should
be construed as investment advice, either on behalf of a particular
security or an overall investment strategy. Neither Nasdaq nor any
of its affiliates makes any recommendation to buy or sell any
security or any representation about the financial condition of any
company. Statements regarding Nasdaq-listed companies are not
guarantees of future performance. Actual results may differ
materially from those expressed or implied. Past performance is not
indicative of future results. Investors should undertake their own
due diligence and carefully evaluate companies before investing.
ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
About Nasdaq:
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing,
exchange technology, listing, information and public company
services across six continents. Through its diverse portfolio of
solutions, Nasdaq enables customers to plan, optimize and execute
their business vision with confidence, using proven technologies
that provide transparency and insight for navigating today's global
capital markets. As the creator of the world's first electronic
stock market, its technology powers more than 70 marketplaces in 50
countries, and 1 in 10 of the world's securities transactions.
Nasdaq is home to more than 3,500 listed companies with a market
value of approximately $9.5 trillion and more than 10,000 corporate
clients. To learn more, visit: nasdaq.com/ambition or
business.nasdaq.com.
NDAQG
Media Relations Contacts:
William Briganti
(646) 441-5012
william.briganti@nasdaq.com
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Apr 2023 to Apr 2024